| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,883 |
16,745 |
$1.24M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,376 |
13,592 |
$703K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,579 |
14,228 |
$630K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,490 |
5,319 |
$400K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
18,936 |
17,473 |
$386K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,141 |
4,065 |
$314K |
| 99215 |
Prolong outpt/office vis |
1,452 |
1,356 |
$137K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,637 |
1,608 |
$121K |
| 96113 |
|
430 |
371 |
$88K |
| 96112 |
|
489 |
416 |
$62K |
| 99493 |
|
334 |
313 |
$31K |
| 99492 |
|
282 |
264 |
$29K |
| 96160 |
|
8,876 |
8,638 |
$24K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
288 |
282 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
890 |
865 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
904 |
877 |
$11K |
| 99381 |
|
94 |
94 |
$8K |
| 99484 |
|
208 |
202 |
$6K |
| 99417 |
Prolong home eval add 15m |
147 |
131 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
179 |
169 |
$4K |
| 96161 |
|
1,238 |
1,201 |
$4K |
| 94760 |
|
2,880 |
2,601 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
68 |
68 |
$3K |
| 0071A |
|
31 |
29 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
157 |
143 |
$2K |
| 96127 |
|
476 |
453 |
$2K |
| 96132 |
|
15 |
14 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
37 |
37 |
$1K |
| 0072A |
|
15 |
14 |
$1K |
| 99173 |
|
650 |
606 |
$823.36 |
| 90686 |
|
3,335 |
2,915 |
$639.52 |
| 99177 |
|
65 |
64 |
$576.13 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
12 |
$368.72 |
| 99000 |
|
460 |
419 |
$323.86 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
13 |
$206.83 |
| 83655 |
|
12 |
12 |
$154.54 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
126 |
109 |
$121.94 |
| 90670 |
|
2,262 |
2,035 |
$108.68 |
| 90648 |
|
2,235 |
2,013 |
$87.81 |
| 90723 |
|
1,097 |
995 |
$19.73 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
13 |
12 |
$4.35 |
| 36416 |
|
39 |
37 |
$3.33 |
| 90680 |
|
777 |
713 |
$2.95 |
| 90696 |
|
15 |
14 |
$0.00 |
| 90651 |
|
13 |
12 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |
| 99072 |
|
194 |
166 |
$0.00 |
| 90734 |
|
16 |
14 |
$0.00 |
| 90633 |
|
147 |
128 |
$0.00 |
| G9920 |
Screening performed and negative |
27 |
26 |
$0.00 |